The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Biovica
Stock and Other Ownership Interests - Biovica; Novartis
Thymidine kinase activity (TKa) as independent predictor of outcome in metastatic breast cancer (MBC) patients in the GEICAM/2013-02 PEARL trial.
 
Angel Guerrero
Consulting or Advisory Role - Exact Sciences; Novartis; Pierre Fabre
Expert Testimony - AstraZeneca; Lilly; Menarini; Novartis; Pfizer; Pierre Fabre
Travel, Accommodations, Expenses - Gilead Sciences; Menarini; Novartis; Roche
 
Miguel Gil Gil
Honoraria - AstraZeneca; Daiichi-Sankyo; Pfizer
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Gilead Sciences; Seagen
Travel, Accommodations, Expenses - Novartis; Pfizer; Roche
 
Amy Williams
No Relationships to Disclose
 
Manuel Ruiz
No Relationships to Disclose
 
Hanna Ritzen
Employment - Biovica
Stock and Other Ownership Interests - Biovica
 
Eva Ciruelos
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; Menarini Group; MSD Oncology; Novartis; Novartis; Pfizer; Reveal Genomics; Reveal Genomics; Roche; Seagen
Speakers' Bureau - Daiichi Sankyo/Astra Zeneca; Lilly; MSD Oncology; Roche
Research Funding - Pfizer; Roche/Genentech (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Pfizer; Roche
 
Montserrat Munoz
Consulting or Advisory Role - Seagen
Speakers' Bureau - Esteve; Gilead Sciences; Gilead Sciences; Gilead Sciences; Roche; Roche
Expert Testimony - Menarini; Novartis
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Daiichi Sankyo/Astra Zeneca; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; Lilly; Pfizer; Roche; Roche; Roche
 
Begona Bermejo
Consulting or Advisory Role - AstraZeneca Spain; Lilly; Menarini; Novartis
Speakers' Bureau - Daiichi Sankyo; Genentech; MSD; Pfizer
Travel, Accommodations, Expenses - Gilead Sciences; Pfizer
 
Mireia Margelí
Consulting or Advisory Role - Daiichi Sankyo; Gylead; Lilly; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
Research Funding - AstraZeneca (Inst); Eisai (Inst); Gylead (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst)
 
Antonio Anton
Consulting or Advisory Role - Daiichi Sankyo/Lilly; Gilead Sciences; Lilly
Speakers' Bureau - AstraZeneca Spain; Daiichi Sankyo/Lilly; Lilly; Novartis; Pfizer; Roche
 
Zsuzsanna Kahan
No Relationships to Disclose
 
Tibor Csoszi
Consulting or Advisory Role - Novartis
Speakers' Bureau - Ipsen; Janssen-Cilag
Travel, Accommodations, Expenses - Pfizer; Sanofi
 
Laura Murillo
No Relationships to Disclose
 
Serafin Morales Murillo
No Relationships to Disclose
 
Istvan Lang
No Relationships to Disclose
 
Jesús Herranz
No Relationships to Disclose
 
Rosalia Caballero
No Relationships to Disclose
 
Helle Fisker
Employment - Biovica
Leadership - Biovica; Flow ROBOTICS; Qlucore AB
Stock and Other Ownership Interests - Biovica; Qlucore
 
Marta Portela
No Relationships to Disclose
 
Miguel Martin
Stock and Other Ownership Interests - Pfizer
Honoraria - Lilly; Novartis; Pfizer; Pierre Fabre; Roche/Genentech; SEAGEN
Consulting or Advisory Role - AstraZeneca; Daiichi-Sankyo; Lilly; Novartis; Pfizer; Roche/Genentech; ROVI Spain; STEMLINE-MENARINI
Speakers' Bureau - Lilly/ImClone; Lilly/ImClone; Pierre Fabre; Roche/Genentech
Research Funding - Novartis (Inst); Puma Biotechnology (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Daichii-Sankyo
Other Relationship - AstraZeneca; Novartis; Roche